Package 71179-816-24

{"route": ["ORAL"], "spl_id": "a2372579-090b-47af-89dc-7adfa36d8cf4", "openfda": {"unii": ["9TN87S3A3C", "6V9V2RYJ8N"], "rxcui": ["1367426"], "spl_set_id": ["a973cb82-1e00-4706-8b96-648135ea48a1"], "manufacturer_name": ["VESPYR BRANDS, INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 BLISTER PACK in 1 CARTON (71179-816-24)  / 8 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "71179-816-24", "marketing_start_date": "20240807"}], "brand_name": "NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS", "product_id": "71179-816_a2372579-090b-47af-89dc-7adfa36d8cf4", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "71179-816", "generic_name": "Naproxen Sodium and Pseudoephedrine Hydrochloride", "labeler_name": "VESPYR BRANDS, INC.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}, {"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA211360", "marketing_category": "ANDA", "marketing_start_date": "20240807", "listing_expiration_date": "20261231"}